Kamada in Largest Commercial Agreement for U.S. Distribution including $180 M of Revenues Over 4 Years

 

• Largest Commercial Agreement in Kamada’s History Becomes Effective in January 2024 and Includes $180 Million of Revenues to Kamada Over the First Four Years of the Eight Year Term
• Financial Terms Reflect KEDRAB®'s Significant U.S. Market Share and Continued Growth Through the Eight Year Term
• Agreement Includes Potential Expansion of Kedrion’s Distribution of KEDRAB in Additional Territories Beyond the U.S.
• Kamada to Host a Conference Call and Live Webcast Today at 8:30 AM ET

Kamada management will host an investment community conference call today, December 6, 2023, at 8:30am Eastern Time to discuss this announcement and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 1-877-407-0792 (from within the U.S.), 1 809-406-247 (from Israel), or 1 201-689-8263 (International) and entering the conference identification number: 13743014. The call will also be webcast live on the Internet at:
https://viavid.webcasts.com/starthere.jsp?ei=1647140&tp_key=4c9e223e0b.

https://www.globenewswire.com/news-release/2023/12/06/2791642/0/en/Kamada-Announces-its-Largest-Commercial-Agreement-A-Strategic-Engagement-with-Kedrion-for-U-S-Distribution-of-KEDRAB-including-180-Million-of-Revenues-Over-First-Four-Years.html